In Switzerland, access to cancer drugs can depend on the insurer
- Words
- 56
- Chars
- 373
- AI summary
- Yes
Swiss health insurers determine on a case-by-case basis whether to pay for certain cancer drugs. This includes medicines used for unapproved purposes or those not on the standard reimbursement list. An evaluation by the Federal Office of Public Health estimated that there were about 38,000 new requests for such coverage.
Swiss health insurers decide case by case whether to cover medicines outside routine reimbursement. These include drugs prescribed for an unapproved use and drugs that are approved but absent from the list of routinely reimbursed medicines. An evaluation commissioned by the Federal Office of Public Health (FOPH) estimated that about 38,000 new requests were submitted […]
Open article